Cancer and Blood Specialists of Arizona Welcome Ronak Rakesh Shah to Its Physician Team
Cancer and Blood Specialists of Arizona (CBSA), a community oncology practice and partner of the American Oncology Network (AON), recently announced the addition of Ronak Rakesh Shah to its physician care team.
Ronak Rakesh Shah is a Board-certified oncologist and hematologist.
He received his medical degree from Michigan State University College of Osteopathic Medicine, completed his residency at McLaren Macomb Hospital, and pursued a fellowship in hematology and oncology at Larkin Community Hospital, an affiliate of Nova Southeastern University in Hialeah, Florida.
The American Oncology Network (AON) (OTCQX: AONC) is a collaborative alliance of physicians and experienced healthcare leaders dedicated to ensuring the long-term success and sustainability of community oncology and other specialties. Established in 2018, AON’s rapidly growing network includes over 290 providers across 21 states.
Through its physician-led model, AON pioneers innovative healthcare solutions that promote value-based care, enhancing patient outcomes while reducing costs and expanding access to quality care.
The network equips its physicians with the resources to thrive independently, offering comprehensive support, revenue-diversifying services, and practice management expertise—allowing doctors to focus on delivering the highest standard of care.
AON is also committed to advancing health equity by addressing disparities in cancer care and ensuring all patients have access to the treatments they need for optimal outcomes. By emphasizing innovation and collaboration, AON is leading the transformation of community oncology.
Cancer and Blood Specialists of Arizona is a team of experienced physicians, nurse practitioners, nurses, and clinical support staff who work together with their administrative support team to provide compassionate, patient-centered care.
With over 40 years of combined experience in the Casa Grande and Flagstaff areas, the physicians are known for delivering high-quality oncologic and hematologic care, grounded in the latest research and clinical expertise.
The team collaborates closely to offer care with empathy, respect, and a holistic approach, always considering what is best for the patient throughout their cancer journey. Recognizing that each patient’s experience is unique, they provide advanced and innovative treatments tailored to each individual to achieve the best possible outcomes and overall experience.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023